肝素的营养调节用于治疗各种贫血状态
Patrizia D'Andrea1,2, Francesca Giampieri1,2, Maurizio Battino1,2,3
1Department of Clinical Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
Nutrients
|December 23, 2023
概括
肝素调节人类的铁平衡,高水平会通过阻断铁的流动而导致贫血. 营养策略可以调节肝素,影响铁的生物可用性和治疗贫血.
科学领域:
- 人类生理学 人类生理学
- 营养科学 营养科学
- 生物化学 生物化学
背景情况:
- 肝素是人类铁平衡的主要调节剂.
- 增加的肝素表达阻断了铁的吸收,从储存中调动和回收,导致贫血.
- 由于高水平的肝素而导致的铁封存涉及给定的铁灭机制.
研究的目的:
- 审查肝素在贫血和铁亡中的作用.
- 总结一下肝素水平的饮食和营养调节.
- 探索与肝素相关的贫血的营养治疗方法.
主要方法:
- 关于肝素,贫血,铁亡和营养的研究的文献综述.
- 综合了关于肝素对铁代谢的影响的发现.
- 对影响肝素表达的饮食因素的分析.
主要成果:
- 肝素的升高与各种贫血症有关.
- 饮食成分和营养素可以调节肝素水平.
- 了解肝素的作用对于管理与铁有关的贫血和铁症至关重要.
结论:
- 肝素在铁调节中的核心作用需要考虑其在治疗贫血症中的调节.
- 针对肝素的营养干预措施提供了一个有前途的治疗途径.
- 需要进一步的研究,以充分阐明肝素与饮食和铁亡的相互作用.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Disorders of Erythrocytes
947
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
947
Erythropoiesis
4.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
706
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
706


